APA (7th ed.) Citation

Fabbiani, M., Di Giambenedetto, S., Ragazzoni, E., Colafigli, M., Prosperi, M., Cauda, R., . . . De Luca, A. (2010). Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. HIV Medicine, 11(5), 326. https://doi.org/10.1111/j.1468-1293.2009.00785.x

Chicago Style (17th ed.) Citation

Fabbiani, M., S. Di Giambenedetto, E. Ragazzoni, M. Colafigli, M. Prosperi, R. Cauda, P. Navarra, and A. De Luca. "Mid-dosing Interval Concentration of Atazanavir and Virological Outcome in Patients Treated for HIV-1 Infection." HIV Medicine 11, no. 5 (2010): 326. https://doi.org/10.1111/j.1468-1293.2009.00785.x.

MLA (9th ed.) Citation

Fabbiani, M., et al. "Mid-dosing Interval Concentration of Atazanavir and Virological Outcome in Patients Treated for HIV-1 Infection." HIV Medicine, vol. 11, no. 5, 2010, p. 326, https://doi.org/10.1111/j.1468-1293.2009.00785.x.